Scarritt Sciences Group Acquires TrialTech Medical

Scarritt Group Expands Capabilities: Adds Subject Recruitment Software and Services

TUCSON, Ariz. and BEVERLY HILLS, Calif., Jan. 19, 2021 (GLOBE NEWSWIRE) — Scarritt Group Inc., a technology-enabled leader in the planning and execution of meetings for Investigators and Coordinators of clinical trials, today announced the acquisition of TrialTech Medical Inc., a leader in the application of cloud- based software and artificial intelligence enabled digital marketing for the recruitment of eligible subjects for clinical trials. The acquisition was completed by Scarritt Sciences Inc., an affiliate of Scarritt Group.

Beverly Hills based TrialTech is a product and services company that facilitates awareness, procures & screens subjects for new clinical trials using their unique, proprietary algorithm.

Trial Tech combines behavioral science research, enhanced digital market targeting, AI, and online behavior analysis, that results in an enhanced quality — as well as higher quantity — discovery of potential trial subjects. The company’s software platform facilitates subject screening, medical record procurement, and transparency between trial sponsors, investigators and sites.

Read more by clicking here

Featured Articles

Featured video

Play Video